Laura
Villaverde Piñeiro
Publicacións (15) Publicacións de Laura Villaverde Piñeiro
2024
-
Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study
Diseases, Vol. 12, Núm. 10
2023
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
-
Evaluación de riesgos en el manejo de equipos para Point-of-Care Testing de ámbito hospitalario. Revisión sistemática
Medicina & Laboratorio, Vol. 27, Núm. 4, pp. 297-313
-
Intravenous and topical sodium thiosulfate for treatment of non-uremic calciphylaxis
Piel
-
Medication experience and patient's related needs in chronic myeloid leukemia treated with tyrosine kinase inhibitors: Systematic review
Farmacia Hospitalaria, Vol. 47, Núm. 2, pp. 85-92
-
Off-label use of guselkumab for pyoderma gangrenosum
Medicina Clinica
-
Risk assessment of Point-of-Care Testing equipment in the hospital environment. Systematic review
Medicina y Laboratorio, Vol. 27, Núm. 4, pp. 297-313
-
Thoughts on the shortage of vinflunine: Could we have done more?
European Journal of Hospital Pharmacy
2022
-
Addressing the at-home care needs of patients with multidrug-resistant bacteria: What should we do?
European Journal of Hospital Pharmacy
-
Capecitabine: Guaranteed access in adjuvant treatment of breast cancer
European Journal of Hospital Pharmacy
-
Defining a new term: Defensive hospital pharmacy practices
European Journal of Hospital Pharmacy
-
Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines
European Journal of Hospital Pharmacy
2020
-
Síndrome de Marfan de presentación atípica, reflejo de una nueva mutación
Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 5, Núm. 2, pp. 87-89
2019
-
Nonalpine epithelioid angiosarcoma of the thyroid in an old woman
Medicina Clinica
2018
-
Paralysis of the external popliteal sciatic nerve associated with daptomycin administration
Journal of Clinical Pharmacy and Therapeutics, Vol. 43, Núm. 4, pp. 578-580